| Literature DB >> 34248399 |
Jing-Sen Chen1, Sheng-Long Cao1, Hai-Ying Hu2, Juan Shen3, Yu-Jun Qi3.
Abstract
In this current experiment, by applying the mixed-ligand synthesis method, twoEntities:
Keywords: Coordination polymers; chronic subdural hematoma; magnetic performances; mixed-ligand
Year: 2021 PMID: 34248399 PMCID: PMC8245070 DOI: 10.1080/15685551.2021.1935535
Source DB: PubMed Journal: Des Monomers Polym ISSN: 1385-772X Impact factor: 2.650
The compounds’ parameters of crystallography as well as the details of refinement
| Identification code | 1 | 2 |
|---|---|---|
| Empirical formula | C78H76Co3N16O18 | C22H20CoN4O5 |
| Formula weight | 1702.33 | 479.35 |
| Temperature (K) | 293.15 | 296.15 |
| Crystal system | triclinic | orthorhombic |
| Space group | P-1 | Pbcn |
| 10.9732(2) | 15.1529(11) | |
| 12.6658(3) | 17.2633(14) | |
| 15.1425(2) | 15.7425(9) | |
| 103.369(5) | 90 | |
| 108.5270(10) | 90 | |
| 95.639(3) | 90 | |
| Volume (Å3) | 1907.48(7) | 4118.1(5) |
| 1 | 8 | |
| 1.482 | 1.546 | |
| 0.727 | 0.877 | |
| Data/restraints/parameters | 9695/3/579 | 5194/0/289 |
| Goodness-of-fit on | 1.197 | 1.068 |
| Final | ||
| Final | ||
| Largest diff. peak/hole/e (Å−3) | 1.13/-0.35 | 0.72/-0.23 |
| CCDC | 2,064,637 | 2,064,638 |
Figure 1.(a) The 1’s asymmetry unit. (b) The one-dimensional loop of [Co2(mbib)2] in complex 1. (c) The 1’s two-dimensional layered net. (d) The three-dimensional packing diagram of the complex 1.
Figure 2.(a) The asymmetry unit of complex 2. (b) The 2’s one-dimensional loop chain architecture. (c) The three-dimensional packing network of complex 2. (d) The interactions of π⋯π between the neighboring chains of the complex 2.
Figure 3.The PXRD models of complex 1 (a) and complex 2 (b). The TGA plot of complex 1 (c) and complex 2 (d)
Figure 4.The temperature dependence of χ and and χ for the complex 1 between 2 and 300 K (a); The 1/χ plot for 1 in 25–300 K (b). The red line indicates the best fit of Curie-Weiss
Figure 5.The temperature dependence of χ and χ for the complex 2 from 2 K to 300 K (a); The 1/χ plot for 2 in 25–300 K (b). The red line indicates the best fit of Curie-Weiss
Figure 6.Compound 1 decreased the pro-inflammatory cytokines content in the hematoma capsule. Intracranial subdural space was injected with the autologous venous blood every two 3-day intervals, the injection of compounds were carried out for the treatment (at 2.5 μg/kg concentration). The enzyme-linked immunosorbent assay detection kit was employed for the pro-inflammatory cytokines determination in the hematoma capsule
Figure 7.Compound enhanced the levels of anti-inflammatory cytokines in the hematoma capsule. Intracranial subdural space was injected with the autologous venous blood every two 3-day intervals, the injection of compounds were performed for the treatment (with 2.5 μg/kg concentration). In the hematoma capsule, the content of IL-10 was determined via applying the enzyme-linked immunosorbent assay detection kit
Figure 8.Both compounds 1 and 2 has no cytotoxicity on the normal human cells. The normal human cells in the logical growth phage were collected and seeded into the 96 well plates. Then, compounds 1 and 2 was added for treatment with serial different dilutions (1, 2, 4, 8, 10, 20, 40 and 80 μM). The viability of the normal human cells was determined with CCK-8 detection